| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | 0.015 | 0.9 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.0095 | 0.9 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |